Logo

Rolf Muller

Jan 06, 2016

BioFluidica has appointed Rolf Muller as CEO. He will assume responsibilities immediately and will succeed Steven Soper, who will remain the company’s chief technology officer. BioFluidica develops technologies for the isolation and analysis of rare, circulating biomarkers in the blood. The company's first platform is being used analyze liquid biopsies to isolate circulating tumor cells and other rare cells from the blood. Prior to joining BioFluidica, Muller was the cofounder and president of Biomatrica. 

Breaking News
The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.